Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1847461-43-1
Purity
95%
Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.
Properties
Name
Mobocertinib
Smiles
COC=1C=C(N(C)CCN(C)C)C(NC(=O)C=C)=CC1NC=2N=CC(C(=O)OC(C)C)=C(N2)C3=CN(C)C=4C=CC=CC34
Targets
Please log in to see this information
SDS
AP-32788 | TAK-788 | mobocertinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$68
2 mg
$72
5 mg
$80
10 mg
$103
15 mg
$118
20 mg
$132
25 mg
$144
30 mg
$152
35 mg
$167
40 mg
$186
45 mg
$198
50 mg
$212
75 mg
$306
100 mg
$POA
Quantity
1
Total amount
$ 80
AP-32788 | TAK-788 | mobocertinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.